"When I was younger and had no idea what was going on, I lived in a constant state of terror. The voices and delusions were ...

Psychedelics have been growing in popularity across North America for recreational and therapeutic use, with celebrities like ...

Even after controlling for a person’s existing substance use and mental health disorders, there remained a 3.5-fold increased ...

Indianapolis police would not confirm if Julius Hill, 25, is still in the hospital, but jail records show he hasn't been ...

Study links hallucinogen use to higher schizophrenia risk, highlighting the need for caution and informed decisions on ...

Insurer access challenges likely lie ahead for the novel schizophrenia drug Cobenfy, given its considerably higher price than ...

A 63-year-old woman authorities say suffers from schizophrenia has been reported missing in Culver City. Michelle Lerner was last seen at 5:41 p.m. Saturday walking near Prospect Avenue and Venice ...

By Puyaan Singh and Bhanvi Satija (Reuters) -AbbVie shares fell over 12% on Monday after an experimental schizophrenia drug ...

AbbVie Inc.’s disappointing trial results for its new schizophrenia drug bode well for rival Bristol Myers Squibb Co., ...

The most common side effects of INVEGA HAFYERA® include: injection site reactions, weight gain, headache, upper respiratory ...

The U.S. Food and Drug Administration has approved Bristol Myers Squibb's Cobenfy (xanomeline and trospium chloride), a first ...

For patients with schizophrenia, repetitive transcranial magnetic stimulation (rTMS) was effective and safe in treating ...